Utility of Four Sarcopenia Criteria for the Prediction of Falls-related Hospitalization in Older Australian Women
Overview
Orthopedics
Authors
Affiliations
Introduction: The aim of this prospective, population-based cohort study of 903 Caucasian-Australian women (mean age 79.9 ± 2.6 years) was to compare the clinical utility of four sarcopenia definitions for the prediction of falls-related hospitalization over 9.5 years.
Methods: The four definitions were the United States Foundation for the National Institutes of Health (FNIH), the European Working Group on Sarcopenia in Older People (EWGSOP), and modified FNIH (AUS-POP) and EWGSOP (AUS-POP) definitions using Australian population-specific cut points (< 2 SD below the mean of young healthy Australian women). Components of sarcopenia including muscle strength, physical function, and appendicular lean mass (ALM) were quantified using hand grip strength, timed-up-and-go (TUG), and dual-energy X-ray absorptiometry (DXA), respectively. Incident 9.5-year falls-related hospitalization were captured by linked data.
Results: Baseline prevalence of sarcopenia according to FNIH (9.4%), EWGSOP (24.1%), AUS-POP (12.0%), and AUS-POP (10.7%) differed substantially. Sarcopenia did not increase the relative hazard ratio (HR) for falls-related hospitalization before or after adjustment for age (aHR): FNIH aHR 1.00 95%CI (0.69-1.47), EWGSOP aHR 1.20 95%CI (0.93-1.54), AUS-POP aHR 0.96 95%CI (0.68-1.35), and AUS-POP aHR 1.33 95%CI (0.94-1.88). When examining individual components of sarcopenia, only muscle strength and physical function but not ALM (adjusted for height or BMI) were associated with falls-related hospitalization.
Conclusion: Current definitions of sarcopenia were not associated with falls-related hospitalization risk in this cohort of community-dwelling older Australian women. Finally, measures of muscle strength and physical function, but not ALM (measured by DXA) may help discriminate the risk of falls-related hospitalization.
Pratt J, Dalla Via J, Sale C, Gebre A, Stephan B, Laws S J Gerontol A Biol Sci Med Sci. 2024; 79(8).
PMID: 38766839 PMC: 11212482. DOI: 10.1093/gerona/glae134.
Voulgaridou G, Tyrovolas S, Detopoulou P, Tsoumana D, Drakaki M, Apostolou T Nutrients. 2024; 16(3).
PMID: 38337720 PMC: 10856900. DOI: 10.3390/nu16030436.
Webster J, Dalla Via J, Langley C, Smith C, Sale C, Sim M Bone Rep. 2024; 19:101684.
PMID: 38163013 PMC: 10757289. DOI: 10.1016/j.bonr.2023.101684.
Stuck A, Basile G, Freystaetter G, De Godoi Rezende Costa Molino C, Lang W, Bischoff-Ferrari H J Cachexia Sarcopenia Muscle. 2022; 14(1):71-83.
PMID: 36564353 PMC: 9891988. DOI: 10.1002/jcsm.13161.
Marincolo J, Aprahamian I, Corona L, Neri A, Yassuda M, Borim F Osteoporos Sarcopenia. 2021; 7(2):69-74.
PMID: 34278002 PMC: 8261724. DOI: 10.1016/j.afos.2021.05.001.